AGC (5201) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Jun, 2026Executive summary
Q1 FY2026 net sales rose by JPY 38.4 billion year-over-year to JPY 538 billion, with operating profit up JPY 12.6 billion, driven by yen depreciation, higher shipments in Essential Chemicals Southeast Asia, and pricing policies in architectural glass in Europe.
Profitability improved in the life science segment and from lower natural gas prices in Europe; profit before tax increased by JPY 18 billion, and profit attributable to owners rose by JPY 16.2 billion.
Net sales for Q1 2026 rose 7.7% year-over-year to JPY 537,965 million, with operating profit up 48.9% to JPY 38,472 million and profit attributable to owners of the parent surging 243.8% to JPY 22,844 million.
Strategic businesses contributed 48% of total consolidated operating profit, with strong performance in Performance Chemicals and Life Science.
Foreign exchange gains and cost reductions contributed to profit growth, while restructuring expenses partially offset gains.
Financial highlights
Net sales: JPY 538 billion, up JPY 38.4 billion year-over-year; operating profit: JPY 38.5 billion, up JPY 12.6 billion year-over-year.
Profit before tax: JPY 35 billion, up JPY 18 billion year-over-year; profit attributable to owners: JPY 22.8 billion, up JPY 16.2 billion year-over-year.
Gross profit increased to JPY 130,410 million from JPY 116,555 million year-over-year.
Free cash flow: minus JPY 17.1 billion, with operating cash flow at JPY 42.6 billion and investment cash flow at minus JPY 59.7 billion.
Cash and cash equivalents increased by JPY 25.2 billion from December 2025 to March 2026.
Outlook and guidance
Full-year outlook remains unchanged from February, with only minimal expected impact from Middle East developments.
FY2026 full-year net sales forecast at JPY 2,200,000 million, up 6.9% year-over-year; operating profit forecast at JPY 150,000 million, up 17.7%.
Q2 is expected to see a dip in both profit and net sales due to seasonality, especially in automotive and electronics.
Strategic businesses are projected to achieve JPY 560 billion in net sales and JPY 80 billion in operating income for the full year.
Dividend forecast unchanged at JPY 210 per share for FY2026.
Latest events from AGC
- Operating profit and ROE improved in FY2025; FY2026 targets further growth and stable dividends.5201
Q4 202513 Apr 2026 - Targets 8% ROE and 10% ROCE by 2026, focusing on growth, reforms, and sustainability.5201
IR Day 2024 Day 231 Jan 2026 - 8% ROE and 440bn yen EBITDA targeted for 2026 via transformation and disciplined investment.5201
IR Day 2024 Day 131 Jan 2026 - Operating and net profit improved despite lower sales, with stable outlook and dividends.5201
Q3 20255 Nov 2025 - Targets net zero carbon by 2050, driven by innovation, ESG, and talent development.5201
ESG Update26 Sep 2025 - FY2025 outlook cut as Chemicals, Life Science, and Electronics underperform; profit rebounds.5201
Q2 20251 Aug 2025 - Global leader in glass, chemicals, and life sciences, driving innovation and sustainable growth.5201
Corporate Presentation7 Jul 2025 - Ambidextrous strategy and sustainability drive growth, digitalization, and profitability targets.5201
Company Presentation7 Jul 2025 - Life Science impairments and Russian exit led to a sharp H1 2024 net loss despite sales growth.5201
Q2 202413 Jun 2025